Key facts
- This page summarizes Gary A. Lyons's Form 4 filing for NEUROCRINE BIOSCIENCES INC (NBIX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 21 May 2026, 19:21.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Additional SEC filing notes
Footnote F1
116,158 of the reported shares are held by the Gary A. Lyons Revocable Living Trust U/A 6/8/12, of which the Reporting Person has voting and investment power
Footnote F2
Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting.
Footnote F3
This RSU award was granted to the Reporting Person on May 21, 2025 and is fully vested.